LifeTech ScientificLFTSF 96 Days Payable is 483.52 as of Dec. 2025, which is 533% above its 10-year median of 76.38. GuruFocus rates LFTSF with a GF Score™ of 96/100 and a GF Value™ of $0.36. The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, LifeTech Scientific ranks better than 89.81% on this metric.
The historical rank and industry rank for LifeTech Scientific's Days Payable or its related term are showing as below:
LFTSF'
s Days Payable Range Over the Past 10 Years
Min: 39.45 Med: 76.38 Max: 339.99
Current: 339.99
During the past 13 years, LifeTech Scientific's highest Days Payable was 339.99. The lowest was 39.45. And the median was 76.38.
LFTSF's Days Payable is ranked better than 89.81% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs LFTSF: 339.99
LifeTech Scientific's Days Payable
increased
from Dec. 2024 (363.34) to Dec. 2025 (483.52).
It may suggest that LifeTech Scientificdelayed paying its suppliers.
LifeTech Scientific Days Payable Related Terms
LifeTech Scientific Days Payable Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LifeTech Scientific's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Days Payable distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
LifeTech Scientific's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (LFTSF) has a Days Payable of 483.52 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on LifeTech Scientific and its competitors. This is 533% above median its historical median of 76.38. Over the past decade, LifeTech Scientific's Days Payable has ranged from 39.45 to 339.99. According to the industry distribution chart, LifeTech Scientific ranks #81 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 10.2%.
Is LifeTech Scientific's Days Payable too high?
LifeTech Scientific's current Days Payable of 483.52 is 533% above median its 10-year median of 76.38. Over the past 10 years, this metric has ranged from a low of 39.45 to a high of 339.99. The Medical Devices & Instruments industry median Days Payable is 68.07. LifeTech Scientific's value of 483.52 is 610.3% above this industry median. Based on the distribution chart, LifeTech Scientific ranks #81 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #81 out of 795 companies for Days Payable. This places LifeTech Scientific in the top 10% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. LifeTech Scientific's value of 483.52 is 610.3% above this benchmark. Historically, LifeTech Scientific's own Days Payable has ranged from 39.45 to 339.99 over the past decade. While the company's 10-year median is 76.38 vs. the industry median of 68.07, LifeTech Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current Days Payable of 483.52 is 610.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current Days Payable is 483.52, which is 533% above median its own 10-year median of 76.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current Days Payable of 483.52. The stock's GF Value™ is $0.36, compared to a current price of $0.23 — trading 35.1% below its estimated fair value. The current Days Payable is 483.52, which is 533% above median its 10-year median of 76.38 and 610.3% above the Medical Devices & Instruments industry median of 68.07. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current Days Payable is 483.52 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (LFTSF) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of $0.23 is trading 35.1% below its estimated GF Value™ of $0.36.
Key valuation signals for LFTSF:
Days Payable: 483.52 (533% above median its 10-year median of 76.38)
GF Value™: $0.36 vs. price of $0.23 (35.1% below fair value)
Industry Position: 610.3% above the Medical Devices & Instruments median (#81 of 795)
No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for LFTSF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFTSF has been successfully added to your 
